Digital
11th and 12th March 2021

2nd Annual MarketsandMarkets Infectious Disease Diagnostics and Point-Of-Care Testing Virtual Conference (Eastern Standard Time)

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

Point-of-care testing (POCT) is a growing testing. Today, you may see POCT in a hospital with handheld gadgets or small testers in emergency department, extensive care setting, popular clinical wards, and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

In the era of improved diagnostics, our 2nd Annual Virtual Event on Infectious Disease Diagnostics and Point-Of-Care Testing will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.

WHAT TO EXPECT

Key Highlights

  • Rapid Screening of Infectious Diseases
  • Microarray technology for diagnostics
  • Application of Point-Of-Care in disease outbreak
  • Advancement of technologies in microbiology and its clinical application
  • Sepsis Detection and its challenges
  • POCT in critical care and applications in patient monitoring

Why Attend?

  • Learn about innovative devices and procedures for effective diagnostics 
  • Meet global heads of diagnostics from the industry and Academics
  • 100+ POCT professionals attending
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions

Who Should Attend?

Hospitals/Universities/Labs

Hospitals- Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department

Designation- Senior scientist, scientist, Microbiologist, biologists, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors, POCT coordinators

Pharma/Therapeutics

Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Online registrations

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

09:00 - 09:10 Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath
PATHOGENS DETECTION NEEDS AT POINT OF CARE

Biosensors and lab-on-chip devices for cancer diagnosis and management

09:10 - 09:40 Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath

The pros and cons of point of care testing for COVID-19 virus: virus, antigens and antibodies

09:40 - 10:10 Alan Wu, San Francisco General Hospital, USA, Clinical Chemistry and Toxicology

How the COVID-19 Exposes the Flaws of Current HealthTesting – Hypermobility & Microfluidics for Health 4.0 Tools for new Medicine

10:10 - 10:40 Dr. Ali Tinazli, Chief Commercial Officer , Fluxergy, USA
CLINICAL APPLICATIONS OF POINT-OF-CARE TOWARDS INFECTIOUS DISEASES

Application of Point-Of-Care in disease outbreak

10:40 - 11:10 Nicola Hodges , Point of Care Coordinator , Royal United Hospitals Bath NHS Foundation Trust, UK

Critical needs of reagents and assay kits to fight COVID-19 and SARS-CoV-2 variants

11:10 - 11:40 Dr. Prajwal Paudel , Product Development Scientist , ACROBiosystems,USA

Blockchain-backed participatory research model for rapid customization of an open Lab on a Chip platform towards emerging challenges in point-of-care diagnostics

11:40 - 12:10 Jens Ducree, Professor of Microsystems in the School of Physical Sciences, Dublin City University (DCU)

Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology

12:10 - 12:40 Dwight Egan, CEO, Co-diagnostic

SARS-CoV-2 & Seasonal Influenza Lateral Flow Multiplex Assays For Point Of Care Or At Home Diagnostic Products

12:40 - 13:10 David Alan Zarling, Executive Chairman and Co-Founder, OptiSomix Incorporated

Closing remarks from the Chairman

13:10 - 13:15

One-to-One networking break| End of Day 1

13:15 - 13:15

Online registrations

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

09:00 - 09:10 Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA
POCT IN CRITICAL CARE

Keynote presentation- Training, competency assessment, and maintaining competency of POC users

09:10 - 09:40 Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

COVID-19 – Pandemic. Managing COVID-19 Respiratory Distress Patients Using an Expanded Test Critical Care Analyzer

09:40 - 10:10 Germano Ferrari , Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK

Reducing Errors at Point-Of-Care

10:10 - 10:40 Uchenna Okeahialam, Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK

Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale

10:40 - 11:10 Vania Silverio , R&D Microfluidics Scientist , INESC-MN, Portugal
PATIENT MONITORING USING POCT

POCT for covid testing and how it has improved during the pandemic?

11:10 - 11:40 Reshma Kadave, Biomedical Scientist & Senior IT Analyst, Imperial College Healthcare NHS Trust, UK

Factors leading to the increase in demand for poct tech and challenges in upholding Quality Standards

11:40 - 12:10 Jyoti Chandok, Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre, Canada

Introduction of galactomannan testing in-house to aid in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA)

12:10 - 12:40 Hannah Lowe, Clinical Scientist , East Kent Hospitals University NHS Foundation Trust, UK

Closing remarks from the Chairman

12:40 - 12:45

One-to-One networking break | End of conference

12:45 - 12:45
CONFERENCE SPEAKERS
Speakers
Jyoti Chandok
Jyoti Chandok
Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre
Pedro Estrela
Pedro Estrela
Director C3Bio - Centre for Biosensors, Bioelectronics and Biodevices, University of Bath, UK
Uchenna Okeahialam
Uchenna Okeahialam
Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK
Hannah Lowe
Hannah Lowe
Clinical Scientist , East Kent Hospitals University NHS Foundation Trust, UK
Vania Silverio
Vania Silverio
R&D Microfluidics Scientist , INESC-MN, Portugal
Germano Ferrari
Germano Ferrari
Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK
Dr. Ali Tinazli
Dr. Ali Tinazli
Chief Commercial Officer , Fluxergy, USA
Robert H. Christenson
Robert H. Christenson
Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA
SPONSORS
Gold
example-image

Fluxergy

example-image

ACROBiosystems

Sponsors & Exhibitors
example-image

Nova Biomedical

Visiting Partners
example-image

Biokit

example-image

Werfen

example-image

Biocartis

example-image

PerkinElmer

example-image

GenMark Diagnostics

example-image

BioMérieux

example-image

GenPrime

example-image

Virion Serion

example-image

Universal Biosensors

Speaking Partner
example-image

Co-Diagnostics

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

Pharma Journalist

example-image

PharmaTutor

PAST EVENT GALLERY
  • Networking-Room
  • Networking-Event
  • Networking-Exhibition-Audience
  • Networking-Exhibition
  • Discussion-Conference-Audience
  • Conference-Speaker
  • Conference-Audience-Discussion
  • Conference-Room-Audience
  • Conference-Room
  • Conference-Audience
  • High Potent Medicines Conference - Networking area
  • High Potent Medicines Conference - Exhibition Area - Booths